William T. Barry, Ph.D.
Affiliations: | 2006 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Biostatistics Biology, Bioinformatics BiologyGoogle:
"William Barry"Parents
Sign in to add mentor| Andrew Nobel | grad student | 2006 | UNC Chapel Hill | |
| (Resampling-based tests of functional categories in gene expression studies.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ligibel JA, Zheng Y, Barry WT, et al. (2023) Effects of an educational physical activity intervention in young women with newly diagnosed breast cancer: Findings from the Young and Strong Study. Cancer |
| Anderson KS, Erick TK, Chen M, et al. (2022) The feasibility of using an autologous GM-CSF-secreting breast cancer vaccine to induce immunity in patients with stage II-III and metastatic breast cancers. Breast Cancer Research and Treatment |
| Parsons HA, Macrae ER, Guo H, et al. (2021) Phase II Single-Arm Study to Assess Trastuzumab and Vinorelbine in Advanced Breast Cancer Patients With HER2-Negative Tumors and HER2-Positive Circulating Tumor Cells. Jco Precision Oncology. 5: 896-903 |
| Tolaney SM, Tayob N, Dang C, et al. (2021) Adjuvant Trastuzumab Emtansine Versus Paclitaxel in Combination With Trastuzumab for Stage I HER2-Positive Breast Cancer (ATEMPT): A Randomized Clinical Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2003398 |
| Ligibel JA, Huebner L, Rugo HS, et al. (2021) Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance). Jnci Cancer Spectrum. 5: pkab025 |
| Tolaney SM, Ziehr DR, Guo H, et al. (2021) Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients. The Oncologist |
| Garrido-Castro AC, Spurr LF, Hughes ME, et al. (2020) Genomic characterization of de novo metastatic breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Lee EK, Xiong N, Cheng SC, et al. (2020) Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial. Gynecologic Oncology |
| Magbanua MJM, Hendrix LH, Hyslop T, et al. (2020) Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapy. Journal of the National Cancer Institute |
| Sella T, Dowton AA, Meyer ME, et al. (2020) The utility of magnetic resonance imaging in early-stage breast cancer survivors-An institutional experience and literature review. The Breast Journal |